7

· PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma

Embed Size (px)

Citation preview

Page 1: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 2: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 3: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 4: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 5: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 6: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma
Page 7: · PDF fileShri Kalyan Nag, Adviser ... dated 10.12.2014 in case of M/S Aristo Pharmaceuticals ... the formulation on the basis of data of M/S Lupin and M/S Ajanta Pharma